# Study Finds That Low BSA Psoriasis Could Have a High Disease Burden

For decades, the severity of psoriasis has been classified on the basis of thresholds reflecting the BSA, or body surface area, impacted by the condition. Under this classification, individuals with less than 3 percent of BSA were categorized as having mild psoriasis; those with a BSA ranging between 3 and 10 percent were regarded as having moderate psoriasis; while those with a BSA in excess of 10 percent were classified as having severe psoriasis.

 As the search to bring to market more efficacious treatments for psoriasis proceeds at companies like Soligenix Inc. (NASDAQ: SNGX), there is an urgent need to…

 Read More>>

 About BioMedWire

 BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

 BMW is where breaking news, insightful content and actionable information converge.

 To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

 For more information, please visit https://www.BioMedWire.com

 Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

 BioMedWireSan Francisco, CAwww.BioMedWire.com415.949.5050 OfficeEditor@BioMedWire.com

 BioMedWire is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/bmw/study-finds-that-low-bsa-psoriasis-could-have-a-high-disease-burden/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/rethinking-psoriasis-new-findings-challenge-traditional-severity-classifications/3e5afb2c55b75c0b2a58faa16c8a1bae) 


Pickup - [https://faqstaq.news/news](https://faqstaq.news/news/202508/152576-understanding-the-impact-of-low-bsa-psoriasis-and-its-high-disease-burden)

Pickup - [https://goinvest.com/ibn-faqstaq](https://goinvest.com/ibn-faqstaq/202508/152501-understanding-the-impact-of-low-bsa-psoriasis-and-its-disease-burden)
 



[Reddit Post](https://www.reddit.com/r/HealthCareNewsInfo/comments/1mr5eqi/rethinking_psoriasis_new_findings_challenge/) 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/258/15/mintoSvm.webp)